Kerget, B. Et Al. 2021. Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.. Journal of medical virology , vol.93, no.4 , 2090-2098.

Kerget, B., Kerget, F., Aksakal, A., Aşkın, S., Sağlam, L., & Akgün, M., (2021). Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.. Journal of medical virology , vol.93, no.4, 2090-2098.

Kerget, Buğra Et Al. "Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.," Journal of medical virology , vol.93, no.4, 2090-2098, 2021

Kerget, Buğra Et Al. "Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.." Journal of medical virology , vol.93, no.4, pp.2090-2098, 2021

Kerget, B. Et Al. (2021) . "Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.." Journal of medical virology , vol.93, no.4, pp.2090-2098.

@article{article, author={Buğra KERGET Et Al. }, title={Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.}, journal={Journal of medical virology}, year=2021, pages={2090-2098} }